Bloomage Biotechnology Corporation Limited — Investor Relations & Filings
About Bloomage Biotechnology Corporation Limited
Bloomage Biotechnology Corporation Limited is a global leader in the research, development, and production of hyaluronic acid and other bioactive substances. Utilizing advanced microbial fermentation and cross-linking technologies, the company provides high-quality raw materials for the pharmaceutical, cosmetic, and food sectors. Its product portfolio includes pharmaceutical-grade sodium hyaluronate, medical devices for ophthalmology and orthopedics, and aesthetic medicine solutions such as dermal fillers. Additionally, Bloomage develops and markets functional skin care brands and health foods. As the world's largest manufacturer of hyaluronic acid, the company maintains a vertically integrated industrial chain, focusing on biotechnology innovation to enhance human health and beauty. Its operations span global markets, serving diverse sectors with high-purity bioactive ingredients and finished consumer products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 致同会计师事务所（特殊普通合伙）关于华熙生物科技股份有限公司非经营性资金占用及其他关联资金往来的专项说明 | 2026-04-22 | Chinese | |
| BloomageBiotech2025SustainabilityReport | 2026-04-22 | Chinese | |
| 华熙生物董事会关于独立董事独立性情况的专项意见 | 2026-04-22 | Chinese | |
| 华熙生物2025年度独立董事述职情况报告（徐文鸣） | 2026-04-22 | Chinese | |
| 华熙生物关于2025年度计提大额资产减值准备的公告 | 2026-04-22 | Chinese | |
| 华熙生物2025年度独立董事述职情况报告（陈达亮） | 2026-04-22 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39083165 | 致同会计师事务所（特殊普通合伙）关于华熙生物科技股份有限公司非经营性资金占用及其他关联资金往来的专项说明 | 2026-04-22 | Chinese | ||
| 39083162 | BloomageBiotech2025SustainabilityReport | 2026-04-22 | Chinese | ||
| 39083156 | 华熙生物董事会关于独立董事独立性情况的专项意见 | 2026-04-22 | Chinese | ||
| 39083152 | 华熙生物2025年度独立董事述职情况报告（徐文鸣） | 2026-04-22 | Chinese | ||
| 39083150 | 华熙生物关于2025年度计提大额资产减值准备的公告 | 2026-04-22 | Chinese | ||
| 39083148 | 华熙生物2025年度独立董事述职情况报告（陈达亮） | 2026-04-22 | Chinese | ||
| 39083146 | 华熙生物2026年度董事、高级管理人员薪酬方案 | 2026-04-22 | Chinese | ||
| 39083145 | 华熙生物会计政策变更公告 | 2026-04-22 | Chinese | ||
| 39083142 | 华熙生物董事会审计委员会2025年度履职报告 | 2026-04-22 | Chinese | ||
| 39083136 | 华熙生物科技股份有限公司2025年度审计报告 | 2026-04-22 | Chinese | ||
| 39083069 | 华熙生物关于2025年度会计师事务所履职情况评估报告 | 2026-04-22 | Chinese | ||
| 39083068 | 华熙生物2025年度独立董事述职情况报告（姚洋） | 2026-04-22 | Chinese | ||
| 39083066 | 华熙生物2025年度独立董事述职情况报告（曹富国） | 2026-04-22 | Chinese | ||
| 39083061 | 华熙生物2025年度业绩快报公告 | 2026-02-27 | Chinese | ||
| 39083054 | 华熙生物关于预计2026年度日常关联交易额度的公告 | 2026-02-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
Bloomage Biotechnology Corporation Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58370/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58370 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58370 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58370 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58370}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bloomage Biotechnology Corporation Limited (id: 58370)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.